USPTO serial 79086116
Y
Reviewed by CopyMark Law Group
Reg. 4024596Status 404
- Filing date
- Status date
- Registration date
- Sep 13, 2011
- Examiner
- MONINGHOFF, KIM TERESA
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Y?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeannine A Rittenhouse
Jeannine A Rittenhouse IpHorgan Ltd.195 Arlington Heights RoadSuite 125Buffalo Grove, IL 60089Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Biological materials, namely, biological reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays for scientific or medical research; proteins intended for producing protein for therapeutic use, namely, protein arrays for scientific and medical research and therapeutic proteins for scientific use in drug discovery ] | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system, the cardiovascular system, the metabolic system, genito-urinary system, the musculo-skeletal system, dermatologic system, alimentary tract, sensory organs, and parasitic diseases, for the treatment of inflammatory disorders for use in dermatology, oncology, hematology and in tissue and organ transplantation and for gastrointestinal disorders; chemico-pharmaceutical preparations, namely, for use in treatment of viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; pharmaceutical preparations used in the treatment of viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; antibiotics; biological, biochemical and biotechnological preparations for medical purposes, namely, for the treatment of neurological, inflammatory, immunological, dermatological, viral, and infectious diseases, infections, parasites, cancer, neurodegenerative diseases, obesity, and diabetes; chemical preparations for pharmaceutical purposes for the treatment of neurological, inflammatory, immunological, dermatological, viral, and infectious diseases, infections, parasites, cancer, neurodegenerative diseases, obesity, and diabetes | SECTION 70 - CANCELLED | — |
| 042 | [ Scientific and industrial research; consulting services in the fields of workplace automation and industrial engineering, namely, development of industrial processes and industrial process automation services; engineering services in the field of reducing operational costs of industrial machinery, namely, development of industrial processes and industrial process automation services; research laboratory services, all of the aforementioned services being in the fields biology, bioinformatics, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, cosmetics and agronomy; industrial and scientific research services in the fields of molecular biology and more specifically genomics, proteomics, protein screening and research into protein interaction ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named Y
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 7, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 7, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 13, 2020 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Sep 14, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 3, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 3, 2018 | INPC | INVALIDATION PROCESSED | — |
| Jul 30, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 30, 2017 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Nov 30, 2017 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Nov 28, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 25, 2017 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 14, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 8, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 8, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 13, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 13, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 4, 2011 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 28, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 28, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 15, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 15, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 26, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 18, 2011 | ALIE | ASSIGNED TO LIE | — |
| May 4, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 4, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 8, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 8, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 28, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 5, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 5, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 4, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 3, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 21, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 17, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 16, 2010 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Sep 16, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |